Extina FDA Approval History
FDA Approved: Yes (First approved June 12, 2007)
Brand name: Extina
Generic name: ketoconazole
Dosage form: Foam
Company: Stiefel Laboratories, Inc.
Treatment for: Seborrheic Dermatitis
Extina Foam is a topical formulation of the antifungal ketoconazole in VersaFoam for the treatment of seborrheic dermatitis.
Development Timeline for Extina
|Jun 13, 2007||FDA Approves Extina for the Treatment of Seborrheic Dermatitis|
|Nov 24, 2004||Connetics Receives FDA Non-Approvable Letter for Extina|
|Apr 8, 2004||Connetics' New Drug Application for Extina Has Been Accepted for Filing by the FDA|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.